Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Sanofi. Director active across 6 companies, notably Icosavax, Inc.. Aggregated, 25 filings have been logged. Split: 21 buys · 0 sell. Total volume traded: €4.4m. History available since 2 August 2021. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sanofi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Sanofi has filed 21 disclosures in total. In the 21 sampled filings, the most common transaction nature is Acquisition, with activity recorded between 2016-01-14 and 2021-09-14, including REGENERON PHARMACEUTICALS INC, ALNYLAM PHARMACEUTICALS, INC., Translate Bio, Inc. and Icosavax, Inc.
